S'abonner

Measuring quality of life in children with rhinoconjunctivitis - 09/09/11

Doi : 10.1016/S0091-6749(98)70380-X 
Elizabeth F. Juniper, MSca, William C. Howland, MDb, Natalie B. Robertsa, Ann K. Thompson, MBAc, Derek R. King, B Matha
Hamilton, Ontario, Canada, Austin, Tex., and Kansas City, Mo 

Abstract

Objective: The objective of this study was to develop, pretest, and validate a questionnaire to measure quality of life in children with seasonal allergic rhinoconjunctivitis (SAR).

Methods (development study): Thirty-four children with SAR were enrolled from summer camps, notices in the media, and an allergy clinic (Southern Ontario). After generating a pool of 48 potentially important quality of life items, the children identified the ones that they experienced with their SAR and scored each for bother (1 = a little bothered to 4 = extremely bothered). Items identified most frequently and with the highest bother score were included in the Paediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ). The PRQLQ was pretested for ease completion and accuracy of understanding.

Results (development study): The PRQLQ has 23 items in five domains (nose symptoms, eye symptoms, practical problems, other symptoms, and activities). Responses are given on a seven-point scale, and children are asked to score their experiences during the previous 7 days.

Methods (validation study): Seventy-five children with symptomatic SAR were enrolled from notices in the media and a pediatric allergy clinic (Austin, Tex.). A single cohort design was used, with children assessed at 0, 1, and 3 weeks. The PRQLQ was administered to the children by a trained interviewer at 1 and 3 weeks. A conventional nasal symptom daily diary was completed for 1 week before each of these clinic visits. Global ratings were completed at the final visit.

Results (validation study): In patients who were stable between clinic visits, the PRQLQ demonstrated good reliability (intraclass correlation coefficient = 0.93). The questionnaire was very responsive to change (p < 0.001) and was able to differentiate between patients who were in a stable clinical state and those whose clinical state changed between visits (p = 0.005). Correlations between the PRQLQ and diary scores were close to predicted and supported both the cross-sectional and longitudinal validity of the PRQLQ.

Conclusions: The PRQLQ measures the quality of life impairments important to children with SAR. Children provide reliable and accurate responses, the measurement properties are strong, and the questionnaire can be used with confidence in clinical trials, clinical practice, and surveys. (J Allergy Clin Immunol 1998;101:163-70.)

Le texte complet de cet article est disponible en PDF.

Keywords : Quality of life, rhinoconjunctivitis, pediatrics

Abbreviations : HRQL:, ICC:, PRQLQ:, SAR:


Plan


 From athe Department of Clinical Epidemiology and Biostatistics, McMaster University Faculty of Health Sciences, Hamilton, Ontario; bHealthquest Therapy and Research Institute Inc., Austin; and cHealth Outcomes Research, Hoechst Marion Roussel Inc., Kansas City.
 Supported by a grant from Hoechst Marion Roussel Inc.
 Reprint requests: Elizabeth Juniper, MCSP, MSc, Department of Clinical Epidemiology and Biostatistics, McMaster University Medical Centre, 1200 Main St. West, Hamilton, Ontario, L8N 3Z5, Canada.
 1/1/86354


© 1998  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 101 - N° 2

P. 163-170 - février 1998 Retour au numéro
Article précédent Article précédent
  • The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis
  • Anjuli S. Nayak, Mark H. Ellis, Gary N. Gross, Louis M. Mendelson, Eric J. Schenkel, Bobby Q. Lanier, Brandon Simpson, Mary Ellen Mullin, Joseph A. Smith
| Article suivant Article suivant
  • Incidence of latex sensitization among latex glove users
  • Gordon L. Sussman, Gary M. Liss, Ken Deal, Shirley Brown, Maureen Cividino, Sidney Siu, Donald H. Beezhold, Gordon Smithb, Mark C. Swanson, John Yunginger, Andrew Douglas, D.Linn Holness, Phyllis Lebert, Paul Keith, Susan Waserman, Kristiina Turjanmaa

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.